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Background
The nosological status of obsessive-compulsive disorder (OCD) is
currently under review. In the National Comorbidity Survey replication
(NCS-R) of US adults, OCD was strongly associated with anxiety, mood,
impulse-control and substance use disorders. Data from the Epidemiolo-
gical Catchment Area (ECA) Study and the NSC-R also identiﬁed a greater
likelihood of bipolar (especially bipolar-II) disorder comorbidity, com-
pared with major depressive disorder in OCD. This study expands
the available knowledge on OCD-comorbidity by investigating the pre-
valence and clinical impact on a group of individuals with OCD or
subthreshold OC syndrome (OCS), prospectively followed-up over an
extended period.
Methods: A stratiﬁed sample of the general population of Zurich,
consisting of 591 subjects (292 males; 299 females) participated in a
series of seven interviews over a 30-year period from age 20–50years.
Psychologists or psychiatrists interviewed participants in their homes
using the SPIKE, a face-to-face interview based upon DSM-criteria that
covered the previous twelve months. The number and percentage of
comorbid disorders were analysed with contingency tables. Odds ratios
and their 95% conﬁdence intervals were estimated with series of bivariate
binary logistic regression models. Longitudinal associations between
repeated distress and lifetime comorbid disorders were examined with
generalized estimating equations. Individuals with OC states, with and
without comorbidity, were compared to determine differences in socio-
demographic factors, clinical characteristics, levels of distress, functional
impairment, suicidality and treatment. Factors related to comorbidity
were examined with series of multivariate logistic regression models.
Meaningful and multivariately predominant predictors were extracted
through the backward stepwise (Wald) exclusion method.
Results: Over the study period, 30 subjects, 11 males and 19 females
(63%), were diagnosed with OCD, 98 with OCS and 107 with OC
symptoms. Lifetime rates of psychiatric comorbidity were high and
increased in prevalence across the OC severity spectrum.
As many as 73% of individuals with OCD experienced an anxiety
disorder and 60% an affective disorder. When compared to controls (i.e.
subjects without any OC symptoms), the lifetime rates of several disorders
were signiﬁcantly associated with OCD(speciﬁcally, generalised anxiety
disorder (GAD) 50%, po0.01; social phobia 40%, po0.01; agoraphobia
30%, po0.01; panic disorder 17%, po0.05; bipolar disorder 40%,
po0.01), whereas unipolar major depression and both alcohol and drug
misuse disorders were not signiﬁcantly more frequently associated with49/$ - see front matter
x.doi.org/10.1016/j.jocrd.2013.04.002any diagnosis of OC severity-spectrum disorders. Most forms of comor-
bidity increased distress and impacted negatively on family and work
relationships, though disorder-speciﬁc effects were observed. Thus, bipo-
lar disorder, agoraphobia and GAD were associated with increased OCD-
severity; bipolar disorder was associated with increased substance abuse
and suicidal acts and panic disorder with increased treatment-seeking
behaviour.
Discussion: In a population-based sample, lifetime rates of psychia-
tric comorbidity were high and increased in prevalence across the OC
severity spectrum. The American Psychiatric Association is actively con-
sidering removing OCD from the Anxiety Disorders group, where it is
categorised in the DSM-IV (www.dsm5.org/). Comorbidity, per se, does
not necessarily imply shared aetiology. The magnitude of the association
that was found in this study between a broad range of anxiety disorders
and OCD, which exceeded the association with lesser OC states, hints that
one distinction between OCD and sub-threshold OC symptoms might
involve the recruitment of neuropsychological mechanisms linked to
pathological anxiety in the full-blown disorder, either as a causal or
consequential factor. From a neuropsychological perspective, our ﬁnding
of a speciﬁc relationship between OC states and bipolarity is intriguing
and is consistent with the existence of as yet poorly deﬁned, overlapping
response-inhibition deﬁcits that could possibly play an aetiological role
both in the development of these disorders and in the progression to
substance abuse and suicidal acts. These hypotheses merit further
exploration using translational paradigms.Social Phobia in Obsessive-
Compulsive Disorder: Prevalence
and Correlates
Assunção M.C.a, Costa D.C.b, Mathis M.A.b, Shavitt R.G.b, Ferrão Y.
A.c, Rosário M.C.d, Miguel E.C.b, Torres A.R.a
a Departament of Neurology, Psychology and Psychiatry, Botucatu
Medical School, São Paulo State University (UNESP)
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Background
Social Phobia (SP) is an anxiety disorder that frequently co-occurs with
obsessive-compulsive disorder (OCD); however, studies that evaluate
clinical factors associated with this speciﬁc comorbidity are rare. The
aim was to estimate the prevalence of SP in a large multicenter sample of
OCD patients and compare the characteristics of individuals with and
without SP.
Method: A cross-sectional study with 1001 patients of the Brazilian
Research Consortium on Obsessive-Compulsive Spectrum Disorders using
several assessment instruments, including the Dimensional Yale-Brown
Obsessive-Compulsive Scale and the Structured Clinical Interview for
DSM-IV Axis I Disorders. Univariate analyses were followed by logistic
regression.
Abstracts / Journal of Obsessive-Compulsive and Related Disorders 2 (2013) 221–231222Results: Lifetime prevalence of SP was 34.6% (N ¼ 346). The
following variables remained associated with SP comorbidity after logistic
regression: male sex, lower socioeconomic status, body dysmorphic
disorder, speciﬁc phobia, dysthymia, generalized anxiety disorder, agor-
aphobia, Tourette syndrome and binge eating disorder.
Limitations: The cross-sectional design does not permit the infer-
ence of causal relationships; some retrospective information may have
been subject to recall bias; all patients were being treated in tertiary
services, therefore generalization of the results to other samples of OCD
sufferers should be cautious. Despite the large sample size, some hypoth-
eses may not have been conﬁrmed due to the small number of cases with
these characteristics (type 2 error).
Conclusion: SP is frequent among OCD patients and co-occurs with
other disorders that have common phenomenological features. These
ﬁndings have important implications for clinical practice, indicating the
need for broader treatment approaches for individuals with this proﬁle.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Comorbid depression in treatment-
refractory OCD. Prevalence, severity
and outcome data for 179 patients
Himanshu Tyagi, MRCPsych, Rupal Patel, MRCPsych
Lynne Drummond MRCP MRCPsych OCD & BDD Service, Springﬁeld
University Hospital, 61 Glenburnie Road, London SW17 7DJ United
Kingdom
Background
Depression is the most common clinical comorbidity in Obsessive
Compulsive Disorder (OCD). Evidence suggests that up to two-thirds of all
patients with OCD can suffer from comorbid depression. In addition it is
widely believed that comorbid depression with OCD leads to a poorer
outcome for treatment. This belief might have some scientiﬁc credence as
depression is shown to impair habituation response, which is required for
a successful exposure and response prevention (EXRP). However, this
question has been poorly researched in the speciﬁc context of treatment
refractory OCD. This study investigated the prevalence of comorbid
depression in patients diagnosed with treatment refractory OCD. As a
secondary objective it compared the response to standard treatment
between the depressed and non-depressed OCD patients.
Method: Our sample constituted of all patients with a primary
diagnosis of treatment refractory OCD who were accepted for outpatient
treatment at a specialist OCD service in London between 1st January 2008
and 30th June 2010. Standardised clinician rated and self-report measures
for assessment of the severity of OCD and depression were completed at
regular intervals (assessment, mid-treatment, discharge from active
treatment, 1 month post discharge, 3 months post-discharge, 6 month
post discharge, 12 months post discharge). Yale Brown Obsessive Com-
pulsive Scale (YBOCS Version 1.0) was used as the primary measure to
assess the severity of OCD. The symptoms and severity of co-morbid
depression were assessed by using Beck Depression Inventory (BDI) and
Montgomery Asberg Depression Rating Scale (MADRS). As a secondary
measure, PADUA inventory was used to assess the nature of the symptoms
of OCD. In addition, routinely collected social and demographic data was
also used to explore the role of any additional factors.
Results: 165 (92.2%) patients out of a total sample of 179 patients
with treatment-refractory OCD were found to have clinically signiﬁcant
depression. This is signiﬁcantly higher than the prevalence reports of
60–70% of comorbid depression in all patients of OCD. To our knowledge,
this is the ﬁrst such estimate of the prevalence of depression in apopulation with treatment refractory OCD. Presence of comorbid depres-
sion did not inﬂuence the treatment response. Improvement in depres-
sion is signiﬁcantly correlated with a successful treatment response
(po0.001). The average improvement in BDI score was 39.5% (SD
43.0%). The average improvement in YBOCS score was 36.5% (SD
36.9%).
The average improvement in the following factors were not found to
be signiﬁcantly associated with
successful treatment response: age of onset of OCD, duration of OCD,
comorbid depression at assessment, severity of depression at assessment,
number of CBT sessions, gender.
References: 1. Timpano KR, Rubenstein LM, Murphy DL. Phenom-
enological features and clinical impact of affective disorders in OCD: a
focus on the bipolar disorder and OCD connection. Depress Anxiety 2011
Nov 22. doi: 10.1002/da.20908.
2. Quarantini LC, Torres AR, Sampaio AS, Fossaluza V, Mathis MA et al.
Comorbid major depression in obsessive-compulsive disorder patients.
Compr Psychiatry 2011 Jul-Aug;52(4):386–93.
3. Abramowitz JS. Treatment of obsessive-compulsive disorder in
patients who have comorbid major depression. J Clin Psychol 2004
Nov;60(11):1133-41.
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Background
Individuals with obsessive-compulsive disorder (OCD) may be gen-
erally less inclined than those unaffected with the disorder to engage in
risky or impulsive behaviours, such as substance use. Cohort studies have
generally shown no elevation of substance use disorder (SUD) rates in
treatment-seeking OCD patients. Interestingly, some but not all epide-
miological studies have shown elevated rates of SUDs among OCD
patients compared with controls. We aimed to investigate the prevalence
and possible impact of SUDs within a large cohort of individuals
with OCD.
Methods: Survey data were derived from the ICOCS database, a
large-scale, multi-centre (10 centres across Europe, Canada, Africa, the
Americas, and the Middle East) database of treatment-seeking individuals
with current OCD (n ¼ 445). Measures relevant to the current investiga-
tion include the Mini International Neuropsychiatric Inventory, the Yale-
Brown Obsessive Compulsive Scale, as well as a demographics
questionnaire.
Abstracts / Journal of Obsessive-Compulsive and Related Disorders 2 (2013) 221–231 223Results: Rates for alcohol abuse (n ¼ 12; 2.7%), alcohol dependence
(n ¼ 7; 1.6%), as well as other drug abuse (n ¼ 1; 0.2%) and dependence
(n ¼ 2; 0.4%) were low. Graphical inspection of the data did not reveal any
obvious differences in SUD prevalence by geographical location. Owing to
such low numbers, the ability to detect possible signiﬁcance in SUD-
related group differences was limited. Nevertheless, those with OCD and
comorbid SUD had numerically more severe OCD symptoms (YBOCS total
score: M ¼ 24.53, SD ¼ 4.21) compared to those without comorbid SUD
(M ¼ 22.44, SD ¼ 7.23; n.s.). In addition, the former group also reported
higher incidence of past depressive episodes (56%) than the latter group
(39%). Incidence of past depressive episodes was not associated with
differences in OCD severity, and no other associations could be observed.
Discussion: These data indicate that SUDs are infrequent among
individuals with OCD, representing a rate reduced by approximately 50%
of that for the normal population. Avoidance of substance use in OCD
appears to be unaffected by cultural and geographical divides. SUD
comorbidity may possibly be associated with greater OCD severity, as
well as a history of more depressive episodes. In summary, reduced SUD
rate in this cohort supports long-standing observations of elevated and
generalized harm avoidance tendencies among individuals with OCD,
which requires further exploration in OCD with and without SUD
comorbidity.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Prevalence of Smoking in Obsessive
Compulsive Disorder (OCD)
Himanshu Tyagi, MRCPsych, Sheetal Sirohi, MRCPsych, Lynne
M Drummond, MRCP MRCPsych
OCD & BDD Service, Springﬁeld University Hospital, 61 Glenburnie
Road, London SW17 7DJ United Kingdom
Background
People with an existing mental illness have a higher prevalence of
smoking tobacco products. In England, 32% of people with a common
mental disorder smoke regularly as compared with 20% of people without
a mental illness (1). More than half (57%) of people attempting suicide in
the past year are also reported to be smokers (1). Current research
suggests that smoking rates may vary with type of mental illnesses. The
highest incidence of smoking has been reported in psychotic illness,
followed by affective disorders. There is a scarcity of research into the
prevalence of smoking in Obsessive Compulsive Disorder (OCD). In
addition there are contradictory reports on the rates of smoking in OCD,
with some researchers reporting it as signiﬁcantly less than that of the
general population and others more in line with the rates seen in other
anxiety disorders and depression. In addition, the differences in the
prevalence of smoking have not been examined in the context of the
severity of the illness.
Method: The sample for this study constituted of all patients with a
primary diagnosis of OCD, who obtained outpatient treatment from a
specialist OCD service in southwest London between April 2009 and April
2010 (n¼154). The rate of smoking in this sample was compared with
another large sample consisting of people receiving outpatient treatment
for serious mental illness (psychosis or treatment refractory depression)
from a community mental health team (CMHT) based in the same
geographical area (n¼324). Smoking data for every patient in our sample
was captured via the clinicians responsible for the care of that individual.
The severity of OCD was determined by using Yale-Brown Obsessive
Compulsive Scale (Version 1), which is a standardised measure.
Results: Patient with severe to profound OCD (YBOCS430) were less
likely to be a current smoker than patients with moderate OCD (YBOCS 16–
30), other psychiatric illnesses or the general population in England(po0.05). However there is no signiﬁcant difference between the smoking
rates between the general population and moderate to severe OCD. No
statistically signiﬁcant difference was found between the severity of OCD or
depression symptoms in current smokers and non-smokers.
Reference: 1. Adult
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Clinical Features of “Pure” Obsessive-
Compulsive Disorder
Torres A.R., Shavitt R.G., Torresan R.C., Ferrão Y.A., Miguel E.C.,
Fontenelle L.F.
Background
Psychiatric comorbidity is the rule in obsessive-compulsive disorder
(OCD). However, very few studies have evaluated the clinical character-
istics of patients with no co-occurring disorders (non-comorbid or “pure”
OCD). The aim of this study was to estimate the prevalence of “pure” cases
in a large multicenter sample of OCD patients and to compare socio-
demographic and clinical characteristics of individuals with and without
any lifetime axis I comorbidity.
Method: Cross-sectional study with 955 adult patients of the
Brazilian Research Consortium on Obsessive-Compulsive Spectrum Dis-
orders (C-TOC). Assessment instruments included the Yale-Brown Obses-
sive-Compulsive Scale, the Dimensional Yale-Brown Obsessive-
Compulsive Scale, The USP-Sensory Phenomena Scale and the Brown
Assessment of Beliefs Scale. Comorbidities were evaluated using the
Structured Clinical Interview for DSM-IV Axis I Disorders. Bivariate
analyses were followed by logistic regression.
Results: Only 74 patients (7.7%) presented “pure” OCD. Compared to
those presenting at least one lifetime comorbidity (881, 92.3%), non-
comorbid patients were more likely to be female and to be working,
reported less traumatic experiences and presented lower scores in the Y-
BOCS obsession subscale and in total DY-BOCS scores. All symptom
dimensions, except contamination-cleaning and hoarding, were less
severe in non-comorbid patients. They also presented less severe depres-
sion and anxiety, lower suicidality and less previous treatments. In the
logistic regression, the following variables predicted pure OCD: sex,
severity of depressive and anxious symptoms, previous suicidal thoughts
and no previous psychotherapy.
Conclusions: “Pure” OCD patients were the minority in this large
sample and were characterized by female sex, less severe depressive and
anxious symptoms, less suicidal thoughts, and fewer use of psychotherapy
as a modality of treatment. Implications of these ﬁndings for clinical
practice are discussed.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Thirty years of clinical trials in
obsessive compulsive disorder:
Excluding the ‘true’ patient?
Odlaug B.L.a,b, Weinhandl E.c, Mancebo M.C.d, Eisen J.L.d,
Rasmussen S.A.d, Schreiber L.R.N.e, Grant J.E.b
a Department of Public Health, Faculty of Health and Medical
Sciences, University of Copenhagen, Copenhagen, Denmark
Abstracts / Journal of Obsessive-Compulsive and Related Disorders 2 (2013) 221–231224b Department of Psychiatry and Behavioral Neuroscience, University
of Chicago, Chicago, IL, USA
c Chronic Disease Research Group, Minneapolis Medical Research
Foundation, Minneapolis, MN, USA
d Butler Hospital and the Department of Psychiatry and Human
Behavior, Brown Medical School, Providence, RI, USA
e Department of Psychiatry, Impulse Control Disorder Clinic, Univer-
sity of Minnesota, Minneapolis, MN, USA
Introduction
Obsessive compulsive disorder (OCD) is one of the most disabling
mental illnesses globally. Over the past 30 years, clinical trials have
resulted in several successful pharmacotherapies for OCD yet patients in
clinical settings often report little or no response. This study compares the
socio-demographic and clinical characteristics of a large sample of
community members with OCD to the inclusion/exclusion criteria used
throughout pharmacotherapy trials.
Methods: The sample was obtained from the Brown Longitudinal
Obsessive Compulsive Study consisting of 325 community members with
a DSM-IV diagnosis of OCD. MedLine, PubMed, and professional library
resources were searched for studies published between 1980–2010 using
the keywords obsessive compulsive disorder, efﬁcacy, pharmacotherapy,
medication, double-blind, placebo-controlled, clomipramine, ﬂuoxetine,
paroxetine, sertraline, and ﬂuvoxamine. We estimated the proportion of
patients in each decade satisfying the most common inclusion/exclusion
criteria (operationalized as criteria present in ≥65% of the clinical trials).
Pearson correlation estimates were calculated among criteria.
Results: Forty-two clinical trials were included in the analysis.
Overall, 72.0% [95% CI: 66.8% - 76.8%] of the 325 subjects included in this
sample would have been excluded from trials conducted between 1980–
2010. The exclusion rate was dramatically lower between 1980–1989
when only 19.7% the sample would have been excluded but rose to 74.8%
for trials conducted between 1990–1999 and 76.9% between 2000–2010.
Conclusions: Over the past 20 years, the majority of community
members with OCD would not qualify for OCD treatment studies due to
high depression scores, co-occurring anxiety disorders, and a failure to
meet threshold criteria for clinical severity based upon measures like the
Yale Brown Obsessive Compulsive Disorder rating scale. Given the low
rates of treatment response and recent trend in pharmacotherapeutic
augmentation studies for OCD, this study illustrates the need to include a
more community-representative sample of patients with OCD in clinical
trials examining pharmacotherapy efﬁcacy.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Shifting and stopping of prospective
memory (PM) responses in obsessive-
compulsive disorder (OCD)
Demeter G.Y.a, Csigó K.b, Harsányi A.b, Németh A.b, Racsmány M.a
a BME, Department of Cognitive Science, Egry József 1, Budapest,
Hungary, 1111.
b Department of Psychiatry, Gyula Nyírő Hospital, Budapest, Hungary
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Introdution
Here we present two experiments aimed to investigate prospective
and inhibitory memory functions in OCD. In the ﬁrst experiment we
adapted an experimental paradigm developed by Burgess et al. (2001),
who demonstrated that different cortical areas are implicated in themaintenance and in the realization of an intention. According to our
results the OCD group performed signiﬁcantly slower on this task than a
matched healthy control group. A further aim of our study was to ﬁnd
different performance patterns related to two subgroups of OCD patients
subdivided by their scores on the Yale-Brown Obsessive Compulsive Scale
(Y-BOCS). The so-called compulsive subgroup performed signiﬁcantly
slower on the expectation condition relative to the baseline condition,
while the obsessive subgroup produced impaired performance on the
execution of the prospective task.
In the second experiment we applied a modiﬁed dual-task paradigm
which required the altered execution and inhibition of responses to the
same secondary task cues. We found that OCD patients made signiﬁcantly
more false alarm type errors and there was a signiﬁcant positive correla-
tion between the number of false alarms and the PM subscale scores of
the Prospective Retrospective Memory Questionnaire (PRMQ). These
results suggest that OCD patients experience difﬁculties during event-
based PM task and that these difﬁculties may originate from over-
monitoring stimuli for possible PM cues and the disinhibition of activated
out-of-date responses.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Obsessions, as problems of thought
suppression; compulsions, as
behavioral-executive impairment
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Introdution
Impairments in executive functioning have been identiﬁed as an
underlying cause of obsessive-compulsive disorder (OCD). Obsessive
patients attempt to suppress certain unwanted thoughts through a
mechanism that Wegner referred to as ‘chronic thought suppression’,
whereas compulsive patients are unable to inhibit their rituals. We tested
51 OCD patients using the Yale-Brown Obsessive Compulsive Scale (Y-
BOCS), the White Bear Suppression Inventory (WBSI) and the Dysexecu-
tive Questionnaire (DEX). Executive functions were tested using a cogni-
tive test battery. We found that the total WBSI score was correlated with
the Y-BOCS obsessive score but not with the Y-BOCS compulsive score. A
stronger correlation was observed between the Y-BOCS obsessive score
and the ‘unwanted intrusive thoughts’ factor based on Blumberg's 3-factor
model of the WBSI. The total WBSI score was not correlated with the
cognitive test results. The DEX score was signiﬁcantly correlated with the
Y-BOCS compulsive score; however, no correlationwas found between the
DEX score and the Y-BOCS obsessive score. A stronger correlation was
observed between the Y-BOCS compulsive score and the ‘inhibition’
component of the DEX score, as deﬁned by Burgess's 5-factor model.
The DEX scores were correlated with cognitive test results measuring
attention, cognitive ﬂexibility and inhibitory processes. We conclude that
obsessions indicate a failure of cognitive inhibition but do not involve
signiﬁcant impairment of executive functions, whereas compulsions
indicate ineffective behavior inhibition and impaired executive functions.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002
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Background
OCD-PANDAS is an immune condition that produces neural alterations
predominantly in fronto-subcortical networks, inducing early onset OCD
(as well as Tics and Tourette). Early onset OCD has been recognized as a
different clinical condition (often more severe) than late onset OCD.
Cognitive and neuropsychological characteristics in PANDAS are insufﬁ-
ciently described in literature, particularly for executive functions (oriented
to characterize frontal-subcortical disfunction). The goal of this study was
to assess the neuropsychological performance of a group of PANDAS.
Methods: We evaluated 22 patients with early onset-OCD whom
have been identiﬁed (conﬁrmed by immunology tests) as possible
PANDAS. Age subject range was10 to 43 years old, all adolescents were
attending school, adults ranged from 10 to 18 school-years. An Executive
function battery (including WCST-64 modiﬁed version, Iowa-type test,
Hanoi Tower, verbal and visual working memory, verbal ﬂuency, Stroop
effect) has been applied. Neuropsychological performance in patients was
compared to a control group paired by age, sex, and school-years.
Results: As a group PANDAS-subjects presented a (statistically sig-
niﬁcant) deﬁciently performance: 1) at the Iowa-type test (with problems
to avoid high risk choices), 2) lower scores in both working memory
modalities verbal and/or visual, 3) Higher number of errors in attention
control (non-stroop type errors), and 4) Problems in classifying categories
(total number of errors at WCST-64 modiﬁed version) and slowness in test
performance (cognitive efﬁciency). Frequency of neuropsychological
alterations in total sample were: 61% in risk-detection, 57% in working
memory (verbal and or visual), 47% in mental inﬂexibility, 42% at risk-
beneﬁt processing, 36% in verbal ﬂuency and 36 % in visual-spatial
planning.
Conclusions: These ﬁndings mainly suggest that OCD-PANDAS have
deﬁcits in frontal-orbital, as well as prefrontal-dorsolateral regions of
the brain.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Olfactory identiﬁcation deﬁcit and its
association to response inhibition in
obsessive-compulsive disorder: on
the scent of the orbitofronto-striatal
model.
G. Bersani a, A. Gallo b, A. Quartini a, F. Ratti a, F.S. Bersani a,
G. Pagliuca b
a DSM ASL/LT-Unity of Psychiatry, Department of Medico-Surgical
Sciences and Biotechnologiesb Unit of Otorhinolaryngology, Faculty of Pharmacy and Medicine -
“Sapienza” University of Rome, “A. Fiorini” Hospital-Terracina (ITALY)
Background
Normal olfactory identiﬁcation (OI) ability is contingent upon the
normal functioning of the orbitofrontal cortex (OFC). Tests of smell
identiﬁcation are a well-recognised means of indirectly assessing the
integrity of the OFC. The fronto-striatal circuitry involving the OFC has
been implicated in the neuropathology of Obsessive Compulsive Disorder
(OCD). However, until today, few studies have assessed the olfactory
function in OCD and of those studies published, the results are mixed.
Aims: To investigate the olfactory and cognitive functions in patients
with OCD compared to healthy control subjects and to relate olfactory
function to neuropsychological performance.
Methods: The Brief Smell Identiﬁcation Test (B-SIT) and tests from
the Cambridge Neuropsychological Automated Battery (CANTAB) were
administered to 30 patients with OCD and to 22 healthy matched controls.
We controlled for age, gender, smoking status and IQ. In OCD patients we
also controlled for symptom severity.
Results: A signiﬁcant impairment in OI ability as well as widely
distributed cognitive deﬁcits in visual memory, executive functions,
attention, and response inhibition were found in OCD patients relative
to controls. Among all the CANTAB tests, and only for the OCD patients,
the degree of behavioural impairment on the response inhibition Stop
Signal Task [slower Stop Signal Reaction Time (SSTR)] strongly correlated
with B-SIT score.
Conclusions: In line with the fronto-striatal dysfunction model of
OCD, we conﬁrmed, in a larger number of subjects, our previous
observation of a common pathologic process underlying OI and response
inhibition impairments in patients with OCD. A slower SSRT has been
associated to impulsive behaviours. This is the ﬁrst study to report OIDs as
a predictor of impulsivity in this clinical population. Further exploration of
the potential diagnostic utility of OIDs in the assessment of OCD would be
useful. Such measures may help delineate the clinical complexity of OCD
and support more targeted investigations and interventions.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Brain imaging correlates of olfactory
dysfunction in OCD
Segalàs C., Soriano-Mas C., Alonso P., Cardoner N., Real E., López-
Solà C., Subirà M., Menchón J.M.
OCD Clinical and Research Unit, Department of Psychiatry, Bellvitge
University Hospital, Barcelona, Spain.
Background
Olfactory dysfunction has been described in several neuropsychiatric
disorders and speciﬁcally in Obsessive Compulsive Disorder (OCD). Brain
regions involved in smell processing in healthy people are overlapped
with structures implicated in the neurobiological bases of OCD. No
previous study has analyzed neuroanatomical correlates of olfactory
dysfunction in OCD. The aim of our study was to examine the association
between regional gray matter volume assessed by a Voxel-based Mor-
phometry (VBM) analysis of Magnetic Resonance Images (MRI) and
olfactory functions, tested by Snifﬁn’ Stick test (SST).
Methods: Olfactory function was assessed in 19 OCD patients and 19
healthy volunteers using the “Snifﬁn’ Stick test”. Images from all the
sample were acquired with a 1.5-T MRI scanner and precessed with SPM8.
Abstracts / Journal of Obsessive-Compulsive and Related Disorders 2 (2013) 221–231226Results: OCD patients showed signiﬁcant impairment in all of the
smell functions (threshold, discrimination and identiﬁcation) assessed
with SST compared to healthy volunteers. Voxel-based mapping of brain
structures in healthy controls revealed signiﬁcant and positive association
between threshold score and increase of gray matter volume of the left
anterior cingulated cortex. In OCD patients a positive correlation was
found between lower identiﬁcation capacity and increase of gray matter
volume of the posterior olfactory sulcus.
Conclusions: Our ﬁndings support the hypothesis that some of the
olfactory dysfunctions described in OCD are associated with volumetric
changes in brain areas implicated in the disorder.
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Context
Subtle cognitive deﬁcits exist in patients with obsessive-compulsive
disorder (OCD) as well as in unaffected relatives, supporting the putative
involvement of frontal and parietal areas in the disorder. We hypothesized
a dysfunctional frontal-parietal working memory circuit in both patients
and unaffected relatives, constituting a potential endophenotype for OCD.
Methods: Forty-three medication-free OCD patients, 17 unaffected
siblings and 37 healthy controls matched on age, gender and IQ under-
went functional magnetic resonance imaging while performing a visuo-
spatial working memory (n-back) task, with a baseline condition and
three load levels of increasing difﬁculty (1-back, 2-back, 3-back). We
compared task (all loads vs. baseline) and load-related activity patterns
between groups using a region-of-interest approach including prefrontal
(bilateral dorsolateral prefrontal cortex, pre-supplementary motor area,
cingulum) and parietal regions (bilateral precuneus and inferior parietal
cortex). Results are reported at po0.05, Family Wise Error corrected.
Results: At 3-back a performance deﬁcit was present in OCD
patients, compared with controls, but not in siblings. Increased task-
related activation in left dorsal prefrontal areas and left precuneus was
found in patients and in an extended network in siblings (bilateral dorsal
prefrontal, parietal and cingulate cortices), compared to controls. How-
ever, from 2-back to 3-back OCD patients showed relative deactivation in
the task-related network in contrast to controls. OCD patients with high
performance showed relatively more hyperactivation than patients with
low performance. No correlation between OCD symptom severity andbrain activity was found. Performance at 3-back correlated with activity in
right pre-supplementary motor area.
Conclusions: Altered activity patterns of the frontal-parietal circui-
try of both OCD patients and unaffected siblings during the n-back task
may constitute an endophenotype for OCD. We suggest that increased
activation in siblings and the high performing OCD patients is compensa-
tory and preserves performance, whereas other OCD patients fail to
adequately compensate, resulting in a performance deﬁcit.
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Background
Increased emotional reactivity in obsessive-compulsive disorder (OCD)
may be due to a deﬁcit in emotion regulation, caused by a failure of
cognitive control exerted by dorsolateral prefrontal cortex (dlPFC). We
hypothesized that 1) during emotion regulation, patients with OCD would
show deﬁcient recruitment of the dlPFC and that 2) stimulating high-
frequency and inhibiting low-frequency repetitive transcranial magnetic
stimulation (rTMS) on the dlPFC would improve cognitive control in
patients, and diminish it in healthy controls, respectively.
Methods: Forty-three medication-free OCD patients and 38
matched controls performed an emotion regulation task with general
fear and OCD-related stimuli during 3-Tesla functional MRI. Pictures were
processed in either an ‘attend’ (passive viewing) or ‘regulate’ (apply
cognitive reappraisal techniques to diminish negative affect) condition.
Subjects rated each picture on a distress scale. Subjects were scanned
twice: at baseline, and after real or placebo rTMS. We assessed effects of
disease-status and rTMS on distress ratings and on brain activity during
emotion regulation.
Results: Patients and controls both showed distress reduction in the
regulate vs. attend-condition at baseline. During fear regulation, controls
recruited the left dlPFC (BA9/46) and bilateral parietal cortex (BA40/7)
signiﬁcantly more than patients. Emotion regulation in patients was
characterized by recruitment of dorsomedial PFC, which was signiﬁcantly
more active during OCD-related regulation in patients versus controls.
Controls in the placebo-condition (p¼ .02) and patients in the
stimulating-rTMS condition (p¼ .10) showed reduced fear distress scores
at day 2 vs. day 1, while scores of controls in the inhibiting-rTMS
condition and patients in the placebo-condition did not change. The
change in distress ratings over sessions correlated with changes of
activation in brain regions involved in emotion processing and regulation.
Conclusions: In line with our ‘emotion-dysregulation’-hypothesis,
patients with OCD showed deﬁcient recruitment of the dlPFC during
emotion regulation. rTMS on dlPFC may affect implicit fear regulation.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002
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Introduction
Neuroimaging studies have provided evidence of cortico-striatal
circuitry dysfunctions in obsessive–compulsive disorder (OCD). Although
previous studies using proton magnetic resonance spectroscopy (1H-MRS)
have shown glutamatergic alterations in these patients, to date no study
has been performed in Pediatric Autoimmune Neuropsychiatric Disorders
Associated with Streptococcal infections (PANDAS) patients that presents
OCD symptoms.
Methods: The aim of this study was to compare, using proton
magnetic resonance spectroscopy (1H-MRS), glutamate levels in the
precommissural dorsal-caudate (or associative striatum) in 17 PANDAS-
OCD patients and 17 age-gender matched controls. All subjects underwent
a 1H-MRS study using a 3Tesla scanner (PRESS, TE¼35ms, TR¼2000ms,
voxels¼8ml). Glutamate levels were estimated with LCmodel software
and corrected for cerebrospinal ﬂuid proportion in the voxel.
Results: Patients showed higher levels of glutamate (T¼4.51,
p¼o0.001), and glutamate + glutamine (T¼2.52, p¼0.017) in the
associative-striatum compared to healthy controls.
Conclusions: The results suggest that a high glutamate level is
present in a brain region previously implicated in the pathophysiology
of OCD.
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Background
Obsessive-compulsive disorder (OCD) is a neuropsychiatric disorder
with a typical onset during childhood or adolescence. Proton magnetic
resonance spectroscopy (1H-MRS) allows in vivo measurements of several
metabolic markers localized in gray and white matter tissues. To date,
however, no in vivo 1H-MRS studies have been published that compare
brain metabolite levels from white matter between patients and controls
under the age of 18. Methods: In vivo brain metabolite levels in the left
and right orbito-frontal white matter (LOFWM, ROFWM, respectively)
were measured in medication-naïve children and adolescents with OCD
(LOFWM: N¼15, mean age 12.9 years, SD¼2.4; ROFWM: N¼16, Mean age
13.2 years, SD¼2.1) and healthy controls (N¼21, Mean age 11.2 years,
SD¼2.7) using in vivo 1H-MRS at 3 Tesla. Spectra were acquired using a
single voxel PRESS sequence (1.5x2.0x2.0cm3, TE/TR¼30/2000ms, 192
averages) and analyzed using LCModel. Metabolite levels were obtained
using the unsuppressed internal water signal method, along with tissue
fractions obtained from tissue segmentation and appropriate relaxation
times.Results: In the ROFWM, children and adolescents with OCD had
statistically signiﬁcant (p ¼ 0.003) higher levels of N-acetyl-aspartate and
a trend towards signiﬁcantly higher levels of glutamate (p ¼ 0.072), even
when controlling for age and sex. In addition, levels of myo-Inositol in the
LOFWM were positively and signiﬁcantly correlated with severity of OCD
symptoms. Discussion/Conclusion: This is the ﬁrst published study of
white matter metabolite levels in children and adolescents with OCD. Our
ﬁndings of case-control differences in brain metabolite levels, lend further
support to the cortico-striato-thalamic-cortical hypothesis of OCD.
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Catechol-O-methyltransferase (COMT) is responsible for dopamine
metabolism and has been thought to play a role in obsessive-
compulsive disorder (OCD)-related pathways by inﬂuencing dopamine
levels. However, the genetic association between COMT polymorphisms
and OCD has not consistent across studies.
Methods: Here, a systematic review and meta-analysis was performed.
To interpret the number of genetic association studies between COMT and
OCD available in the literature, the Venice Interim Guidelines was established
for determining the credibility of the related cumulative evidence.
Results: The systematic review found 23 studies and 21 of them
were included in the meta-analysis. Results of the present meta-analysis,
together with the literature review, added to the accumulated evidence
suggesting a weak association between variants in the COMT Val158Met
polymorphism and OCD.
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Objective
The objective of the present study was to examine association
between monoamine oxidase A (MAO-A) polymorphisms and obsessive-
compulsive disorder (OCD) related phenotypes in 83 Brazilian trios.
Methods: The study sample comprised 83 OCD probands and their
parents. Six single-nucleotide polymorphisms were genotyped and trans-
mission disequilibrium was analyzed.
Results: MAO-A was associated with a broadly-deﬁned OCD pheno-
type (when 75% of DSM IV criteria for OCD was met) as well as with OCD
spectrum disorders (i.e., anxiety disorders, body dimorphic disorder, skin
picking and trichotillomania).
Conclusions: The association between MAOA and obsessive-
compulsive symptoms as well as OCD spectrum disorders could bolster
the notion that altered MAO-A function inﬂuences different neurotrans-
mitters and pathways, resulting in low speciﬁcity for behavioral changes.Further association studies of OCD-related phenotypes, involving larger
independent samples, are required.
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Abstract
Several studies demonstrated that a single nucleotide polymorphism
(SNP), –1438G/A (rs6311), found in the transcriptional control region of
the gene that encodes the serotonin-receptor 2A (HTR2A) is associated
with obsessive-compulsive disorder (OCD) in particular with the early
onset form, starting by age 10. A meta-analysis of our results as well as
many other published results point to its association with early-onset
OCD. Several studies investigated the effects of the HTR2A imprinting on
expression, but up to now there are conﬂicting results. Still several
epigenetic studies suggested that the rs6311 SNP affects methylation
status of the promoter region and therefore affects the transcription of
HTR2A. Here we investigated in post-mortem brain tissue (in several
different brain regions) the transcriptions of HTR2A and correlated it to
the developmental stage of the brain (41-weeks foetus in uterus to 85
years old age controls), as well as to the genotype of each of the subjects.
The knowledge arising from this study will enable to understand the
functional effect of this polymorphism on brain development and expres-
sion of the excitatory receptor HTR2A in different brain regions.
http://dx.doi.org/10.1016/j.jocrd.2013.04.002Association study between BDNF
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Association between Brain-Derived Neurotrophic Factor (BDNF) gene
and Obsessive Compulsive Disorder (OCD) was reported in a family-based
association study. In this study, we investigate the role of BDNF poly-
morphic variants (rs6265, rs1519480 and rs7124442) in OCD Mexican
patients using a case-control and family-based association design.
Material and Methods: Our sample consisted of 190 OCD
patients, 283 control subjects and 109 OCD families. OCD patients fulﬁlled
DSMIV-TR diagnostic criteria and were captured from Instituto Nacional
de Psiquiatría Ramón de la Fuente Muñiz and Grupo Médico Carracci. DNA
analysis of rs6265, rs1519480 and rs7124442 was performed using Taq-
Man allelic discrimination assays. Single SNP and haplotype analyses were
conducted to determine association between BDNF variants and OCD.
Results: Case-control analysis showed a signiﬁcant association
between rs6265 and OCD. We observed a high frequency of Val/Val
genotype and Val allele in OCD patients compared with controls (χ2¼21.8,
p¼0.0001; χ2¼22.7, p¼0.0001, respectively). Also, rs1519480 analysis
showed a high frequency of G allele in OCD patients compared with
control group (χ2¼27.8, p¼0.0001). Haplotype analysis showed a high
frequency of A-A-T in OCD compared with control group showing a 2.1-
fold increased risk of OCD (p¼0.014). Clinical characteristics did not show
signiﬁcant differences in SNP and haplotype-based analysis. Finally, the
family-based association study did not show linkage disequilibrium.
Conclusions: We replicated the association between Val allele of
rs6265 BDNF gene polymorphism and OCD. We found signiﬁcant associa-
tion of rs1519480 in OCD patients compared with a control group. Finally,
we observed a high risk haplotype (A-A-T) in OCD patients and a
protective A-G-T haplotype for OCD. Interestingly, the risk to develop
OCD could be dependent of being a carrier of A variant of rs1519480,
region that has never been analyzed in OCD. Therefore, our ﬁndings
suggest that BDNF gene could be related to the development of OCD.
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Background
An imbalance between pro and anti-inﬂammatory cytokines has been
described in psychiatric disorders, such as depression and schizophrenia.
Immune dysregulation has been hypothesized to play a role in at least
some cases of OCD. Studies of cytokines in OCD patients have shown
contradictory results and some studies have shown that speciﬁc obsessive
compulsive symptoms are associated with speciﬁc cytokines.
Objectives: The aim of this study was to evaluate the association
between cytokine proﬁles and OCD severity in OCD patients before and
after intervention as compared to healthy controls.Methods: Plasma levels of pro-inﬂammatory (IL-1α, IL-1β, IL-2, IL-6,
IL-8, TNFα and IFNγ) and anti-inﬂammatory (IL-10, IL-4, TGFβ) cytokines
were evaluated in 70 OCD patients and 101 healthy controls. Clinical and
immunological evaluations were performed at baseline and 12 weeks
later after treatment. The second assessment was performed in 43 OCD
patients (59.7%) and 87 healthy controls (86.1%).Cytokine levelswere
analyzed by glass chip-based-Ab microarrays. Generalized estimating
equations were applied to determine associations between cytokines
(continuous and binary) and OCD diagnosis and severity, after controlling
for psychotropic medication.
Results: Thirty (43%) OCD patients presented with depression (MDD
and/or Dysthymia). Cytokine proﬁles were similar in OCD patients with
depression, OCD patients without depression, and healthy controls; and
also in OCD patients before and after treatment. There was no signiﬁcant
association between cytokine levels and YBOCS scores, or between
cytokines levels and Beck Depression scores. However, log10 TNFα was
associated with reduction in YBOCS scores (0.0104; p¼0.047); the pre-
sence of IL-1β was associated with 81% reduction of YBOCS scores (-0.201,
p¼0.046); and the presence of IFNγ (0.2739, p¼0.028) was associated
with 31% increase of YBOCS scores.
Conclusion: OCD patients (with and without depression) did not
exhibit different cytokine patterns compared to healthy controls. How-
ever, speciﬁc cytokines were associated with OCD severity and treatment
response.
Financial Support: NARSAD Joan Granlund Investigator Award,
FAPESP (Fundaçao de Amparo à Pesquisa do Estado de Sao Paulo, BRAZIL)
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Introduction
Streptococcal infection can lead to an autoimmune disease character-
ized by a spectrum of psychiatric disorders called PANDAS (Pediatric
Autoimmune Neuropsychiatric Disorders). It has been suggested the
involvement of the serotoninergic system in the pathophysiology of
obsessive-compulsive disorder (OCD), supported by the therapeutic
efﬁcacy of selective serotonin reuptake inhibitors (SSRI). Similarly, it is
known that serotonin is involved in immunological processes as reported
in atopic dermatitis, and the inﬂuence of serotonin concentration may
Abstracts / Journal of Obsessive-Compulsive and Related Disorders 2 (2013) 221–231230modulate 5-HT1A autoreceptors due to psychological stress. Those indi-
viduals, carriers of a particular genotype of 5-HTT, could be related to the
amount of antibody titers associated with PANDAS.
Objective: This study assessed the association between 5-HTT
genotypes and antibody titers (anti-streptococcal (AS), anti-neural from
brain lysate glycoproteins (AN), and anti-enolase (AE)) associated with the
PANDAS phenotype in patients from Mexico City and Cuba.
Methods: The study has been approved by an independent ethics
committee; all enrolled patients provided a written informed consent.
OCD-PANDAS was diagnosed in 50 patients from Mexico and Cuba,
according to current clinimetric standards. It was determined the pre-
sence of 3 antibodies AS, AN, and AE by ELISA. Besides, DNA from
peripheral blood was extracted for 5-HTT genotyping.
Results: The sample was divided into three genotypes (LL, SL and SS)
and compared to titers of the three antibodies. Statistically signiﬁcant
differences were observed between the titers of AN with SL and SS
genotypes (p ¼ 0.045) and also between LL and SS genotypes (p ¼
0.018). Individuals with SS genotypes had higher levels of antibodies that
LL. In addition individuals with the SS genotype had also a higher number
of titles of AE comparing LL vs SL/SS genotypes (p ¼ 0.0018). No differences
were found for the AS.
Acknowledgments: We thank ICYT-DF for the support given to
this project.
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Background
Non-response to serotonin reuptake inhibitors (SRIs) represents a
challenge in obsessive-compulsive disorder (OCD) treatment. Usually, at
least 12-weeks are necessary to determine that a patient was not
responsive to a SRI. However, early predictors of non-response may be
useful to determine if additional interventions can be implemented in the
short term. We aimed to investigate if early improvement (at 4 weeks) is a
predictor of OCD outcome after 12 weeks.
Methods: We performed a secondary analysis of the results of an SRI
trial conducted with 145 OCD patients admitted to an outpatient clinic.
Inclusion criteria: age between 18-65 years, DSM-IV primary diagnosis of
OCD, minimum baseline Y-BOCS score of 16 and absence of previous
adequate pharmacological treatment for OCD. Systematic assessments on
OCD severity were taken at baseline, weeks 4 and 12. Treatment response at
12 weeks was deﬁned as 35% or greater decrease in baseline Yale-Brown
Obsessive-Compulsive Scale (Y-BOCS) score. Stepwise logistic regression was
used to test the relationship between early improvement (at 4 weeks) and
treatment response (at 12 weeks) taking into account socio-demographicand clinical characteristics. Different thresholds of early improvement were
tested and the sensitivity and speciﬁcity of each cut-off point were
calculated.
Results: Early improvement deﬁned as a 20% reduction from base-
line Y-BOCS scores was able to predict 12-weeks response with 78.4%
sensitivity and 60.5% speciﬁcity. According to the logistic regression
model, only early improvement remained associated with treatment
response after 12 weeks (Odds Ratio¼ 1.14, po0.0001). Only 17 out of
97 patients who have not improved at week 4 were responders at week
12 (Pearson Chi-Square¼ 20.6, po0.001).
Conclusions: Early improvement predicted 12-week outcome of
OCD with good sensitivity and speciﬁcity. Its role in early decision making
should be investigated in future studies.
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Background
The aim of this study was to investigate the therapeutic efﬁcacy of
repetitive transcranial magnetic stimulation (rTMS) of the supplementary
motor area (SMA) in treatment-refractory OCD.
Methods: We recruited 11 refractory-OCD patients (6 males and
5 females, mean age 33.36711.96 ), with a Y-BOCS score 416 (enroll-
ment is still in progress). All of these patients underwent a simultaneous,
bilateral and low frequency (1Hz) SMA-rTMS as an add-on treatment.
Refractoriness (indicated by the lack of a signiﬁcant Y-BOCS score
reduction, o35%), was deﬁned as no/insufﬁcient response following at
least two trials with SSRI and one with clomipramine. There was no
change of drug therapy for any patient during the study. Patients under-
went 15 rTMS sessions (1 per day, 5 per week for 3 weeks). We used
Magstim Rapid Stimulator generating biphasic pulses (Magstim Company,
Ltd., Whitland, U.K.) with a focal 70-mm, 8-shaped coil. OCD, mood and
anxiety symptoms, were rated at baseline, at the 2nd and at the 3rd week,
according to Y-BOCS, HAM-A and HAM-D. We assessed rTMS-treatment
effects with a two-way analysis of variance (ANOVA), considering time as
indipendent factor and rating scale scores as dependent variables.
Results: After 2 weeks of stimulation 4/11 patients (36.4%) resulted
responders (425% Y-BOCS score reduction) and 1/11 remitter (YBOCS
score o18). At the end of the 3rd week, 7/11 patients (63.6%) and 3/11
(27.3%) were respectively responders and remitters.
Conclusion: Bilateral, simultaneous and low frequency SMA-rTMS
showed to produce a signiﬁcant improvement in refractory OCD patients,
after 3 weeks of stimulation. Further research is needed to establish any
differences using a longer period of stimulation, a major sample of
patients and a sham-stimulated control group.
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Background
Over the past several decades, our understanding of the biological
underpinnings of Obsessive Compulsive Disorder (OCD) has signiﬁcantly
increased. There is a general consensus that OCD is associated with
abnormalities in the cortico-striato-thalamo-cortical circuitry. Pharmaco-
logical treatment investigations have focused on the role of the neuro-
transmitters serotonin and dopamine. Evidence-based, ﬁrst-line
treatments for OCD include the serotonin reuptake inhibitors (SRI),
however, 40-60% of OCD patients do not respond. A wide variety of
agents have been examined as adjuncts to standard SRI treatment in cases
of treatment resistance, however, no gold-standard approach has been
identiﬁed. Glutamate dysfunction is now thought to have a role in OCD,
and use of glutamatergic treatment agents may hold promise. N-
acetylcysteine (NAC) is an amino acid derivative of cysteine, avaliable as
a health supplement. It has shown efﬁcacy in OCD-spectrum disorders
and in 1 case report of treatment resistant OCD. METHOD: A retrospective
chart review of 6 treatment resistant OCD patients who had been treated
with NAC for 6-12 weeks. Symptom severity was evaluated at regular
clinic visits. RESULTS: Five of 6 patients took NAC for 12 weeks. The mean
endpoint dose was 2833.3 7 408.2 mg/day. Only one of the six patients
responded to treatment with NAC; two patients reported a worsening of
symptoms; no patients reported adverse events. CONCLUSIONS: NAC was
not effective in this sample of treatment -refractory OCD patients.
Whether this result was a function of the mechanism of action of
NAC or of the pathophysiology of treatment refractory OCD, remains
unclear.
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Objective
This study aimed to examine the prevalence of metabolic syndrome
(MetS) in patients with obsessive-compulsive disorder (OCD).
Method: This cross-sectional analysis was performed on 58 out-
patients with OCD treated in Şişli Etfal Teaching and Research Hospital
Psychiatry Department Istanbul Turkey between June 2009 and December
2009. Study population comprised 44 female (75.9%) and 14 male (24.1%)
subjects with a mean age of 36.16711.61 years. Psychiatric diagnoses
were evaluated using Structured Clinical Interview for DSM- IV (SCID-I).
Subjects having three or more of the NCEP Adult Treatment Protocol III
criteria were deﬁned as having MetS.
Results: Of the overall population, 11 (19%) had MetS. There was no
signiﬁcant difference between the genders in terms of meeting thecriteria for MetS (for females 7/44, 15.9% and for males 4/14, 28.6%;
p¼0.29). The patients with MetS was signiﬁcantly older than the patients
without MetS (46.8278.41 years vs. 33.66710.86 years, po0.001). The
components of MetS did not differ signiﬁcantly between patients using
and not using antipsychotics except HDL cholesterol which was signiﬁ-
cantly lower in patients treated with antipsychotics (48.74710.88 mg/dL
vs. 56.90713.34 mg/dL, p¼0.02).
Conclusion: Despite the antipsychotic augmentation, the preva-
lence of MetS (19%) was relatively low among patients with OCD.
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Background
Gender plays an integral part in the perception of one’s own body
image. However, existing treatments for body image disorders do not use
sophisticated gender speciﬁc approaches to treatment. A relative lack of
research in the gender speciﬁc factors appears to be one of the main
contributory factors for this discrepancy. This study investigated simila-
rities and differences in patients with Body Dysmorphic Disorder (BDD).
Method: We investigated 54 patients with a diagnosis of BDD, who
were assessed between 2008 and 2011 at a specialist centre for OCD and
BDD, based in southwest London, UK. Routinely collected standard
measures at the time of assessment i.e. Yale Brown Obsessive Compulsive
Scale (YBOCS-BDD), Body Dissatisfaction Checklist, Beck Depression
Inventory (BDI), Montgomery-Asberg Depression Rating Scale (MADRS),
Sheehan Disability Scale (SDS) and sociodemographic information (rela-
tionship and employment status) were collated and analysed with respect
to gender. Self-report questionnaires i.e. Body Dissatisfaction Checklist,
BDI and SDS were completed by the patients prior to the assessment
interview. Assessment interviews were conducted by clinicians with
speciﬁc expertise in the treatment of BDD. Data on the preoccupation
with body parts was primarily collected from body dissatisfaction check-
list and was supplemented with information reported elsewhere in the
assessment and treatment reports.
Results: There were more similarities than differences between the
two genders.
Our data suggested that females were more likely to present late for
treatment and also not be in a stable relationship at the time of
presentation. Males were noted to be less likely to be employed. Males
scored slightly higher on all clinician rated instruments i.e. YBOCS- BDD,
BDI, MADRS and SDS. However none of these demographic or clinical
factors were found to have a statistically signiﬁcant difference between
the two genders.
Males and females did not signiﬁcantly differ in terms of most of the
variables on body dissatisfaction checklist. Statistically signiﬁcant differ-
ences were found only in preoccupation with breasts, hips, skin (face and
body) and hair (facial hair and corporal hair, except scalp hair). Our results
are similar to previously reported ﬁndings in the literature (1).
References: 1. Phillips KA, Diaz SF. Gender differences in Body
Dysmorphic Disorder. J Nerv Ment Dis. 1997 Sep;185(9):570-7.
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